Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr David Dodwell

Dr David Dodwell

Contact information

Email
david.dodwell@ndph.ox.ac.uk

Telephone
01865 743562

David Dodwell

BSc, MD, FRCP, FRCR

Senior Clinical Research Fellow

David is a senior breast oncologist with a number of research and governance interests.

He is the lead oncologist on the Sloane and NHS breast screening audits and co-lead for the national audits in primary and metastatic breast cancer.

Recent publications

Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023).

Perletta V. et al, (2026), ESMO Real World Data Digit Oncol, 12

The National Audit of Metastatic Breast Cancer (NAoMe): Sharing Key Findings and Recommendations From the 2025 State of the Nation Report.

Hanbury G. et al, (2026), Clin Oncol (R Coll Radiol), 52

Reducing locoregional treatments in low risk early invasive breast cancer.

Potter S. et al, (2026), Eur J Surg Oncol, 52

Impact of sex on chemotherapy toxicity and efficacy in biliary tract cancer: Analysis of ABC, BILCAP trials and population data.

Wagner AD. et al, (2026), JHEP Rep, 8

Clinical Impact of Next-Generation Sequencing-Guided Targeted Therapies in Advanced Cancer: A Systematic Review and Meta-Analysis.

Kazmi F. et al, (2025), Clin Oncol (R Coll Radiol), 48

More publications